People paying privately for weight-loss drug Mounjaro in the UK face a rise in the cost of the treatment after manufacturer Eli Lilly said it was increasing the list price of the drug by as much as 170%.

Eli Lilly will raise the UK list price of its weight-loss and type 2 diabetes treatment Mounjaro by up to 170% to be in line with other European markets, it said on Thursday, as the pharma industry responds to U.

Eli Lilly is set to significantly hike the UK price of its weight-loss and diabetes medication Mounjaro, with some dosages expected to see a staggering 170 percent increase starting from September.